Wednesday, November 27, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott ...

NRx Pharmaceuticals (NRXP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Alexandria Real Estate Equities Inc.’s ARE premium portfolio of Class A/A+ properties in strategic markets is well-poised to ...

SEOUL, Korea, Republic Of (AP) — SEOUL, Korea, Republic Of (AP) — KT Corp. (KT) on Tuesday reported earnings of $263.7 million in its third quarter. On a per-share basis, the Seoul, Korea, Republic Of ...

The consumer is the engine of the United States economy, representing more than two-thirds of the country's entire GDP. By ...

Stanford University medical professor Dr. Bryant Lin was diagnosed with stage IV lung cancer despite never smoking. Now, he's ...

FRANKLIN, Ind. (AP) — FRANKLIN, Ind. (AP) — IBC Advanced Alloys Corp. (IAALF) on Wednesday reported a loss of $1.2 million in its fiscal first quarter. On a per-share basis, the Franklin, ...

In a report released today, Celine Pannuti CFA from J.P. Morgan maintained a Hold rating on British American Tobacco (BATS – Research Report), ...